Press Releases

These press releases are intended as reference information for U.S. investors and journalists. These press releases correspond to each fiscal quarter ended and should not be deemed accurate or current except as of the date of the particular press release.

Athersys, Inc. has no intention of updating any of the information contained in previously issued press releases and specifically disclaims any duty to update such information. Readers are urged to refer to the most recent press release and SEC filings for the most current information
 

All Releases
Athersys Announces Expansion of Collaboration With Healios
Jun 7, 2018
CLEVELAND, Ohio, June 07, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX ) announced today that it has entered into an agreement with HEALIOS K.K. (“Healios”) to expand their collaboration into additional therapeutic areas. Under the terms of the agreements, Healios obtained exclusive
Athersys Reports First Quarter 2018 Results
May 10, 2018
Management to host conference call at 4:30pm EDT today
Athersys and Healios Extend by One Month the Period to Complete Collaboration Expansion Agreements
May 1, 2018
CLEVELAND and TOKYO , May 01, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) and HEALIOS K.K . ("Healios") (TSE Mothers Code:4593) have agreed to extend the period from April 30, 2018 to May 31, 2018 to complete their planned collaboration expansion agreements, as defined in the March 13,
UTHealth in Houston and Athersys Announce Funding for Clinical Trial using MultiStem® to Treat Trauma Patients
Apr 23, 2018
Pioneering Phase 2 study of cell therapy in Trauma to be conducted at major Level 1 Trauma Center in the U.S. with funding from MTEC Grant Award
Athersys to Host First Quarter Financial Results Call
Apr 12, 2018
CLEVELAND , April 12, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its first quarter 2018 financial results at approximately 4:00 PM Eastern Time on Thursday, May 10, 2018 , and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results.
Athersys to Present at Needham Healthcare Conference on March 28
Mar 20, 2018
CLEVELAND , March 20, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen , Chairman and CEO, will present a corporate overview at the 17 th Annual Needham Healthcare Conference at The Westin Grand Central Hotel in New York City.  The presentation is
Athersys Reports Financial Results for Fourth Quarter, Full Year 2017
Mar 13, 2018
Company also announces equity investment and binding letter of intent to expand  HEALIOS K.K. collaboration, covered in a separate release Management to host conference call at 4:30 PM EDT today CLEVELAND , March 13, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc.
Athersys and Healios Announce Binding Letter of Intent to Expand MultiStem® Collaboration
Mar 13, 2018
Equity investment and binding letter of intent outlines expansion of Japan collaboration, including exclusive option for China development and commercialization Benefits to include consolidated development of MultiStem indications in key Asian markets, provision of capital to Athersys for support
Athersys to Host Year-End 2017 Financial Results Call
Feb 12, 2018
CLEVELAND , Feb. 12, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its year-end 2017 financial results at approximately 4:00 PM Eastern Time on Tuesday, March 13, 2018 , and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results.
Athersys Enters Into New $100 Million Equity Facility with Aspire Capital
Feb 2, 2018
Provides access to capital to support ongoing business and development objectives CLEVELAND , Feb. 02, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) and Aspire Capital Fund , LLC ("Aspire Capital") announced today that a new equity facility has been established, as a follow-on to a current